Bamlanivimab and Etesevimab Infusion, Home or Residence

Name: Negotiated commercial rates for Bamlanivimab and Etesevimab Infusion, Home or Residence (HCPCS M0246), in Rhode Island
Creator: Tynbil
License: https://tynbil.com/terms

Rhode Island rates for HCPCS M0246

Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency

Rates data updated July 2026.

Rates by insurance carrier

Insurance Carrier	Facility/Professional	Modifier	Typical Low	Median	Typical High